FDA Ad Com for Cardinal Health's Incraft stent June 12

|About: Cardinal Health Inc. (CAH)|By:, SA News Editor

The FDA's Circulatory Systems Devices Panel will meet on Tuesday, June 12, to discuss Cardinal Health (CAH +0.4%) unit Cordis' marketing application seeking approval for its Incraft AAA stent graft system.

FDA briefing doc

Company briefing doc